5 clinical trials found.
-
Single-Center Pilot Study of Living Donor Kidney Transplant from HIV-positive Donor to HIV-positive Recipient
This study will evaluate the feasibility and safety of living donor kidney transplant from an HIV-infected donor to an HIV-infected recipient.Phase N/A
Interventional
TRIAL ROLE: Co-Investigator
-
A Randomized Open-Label Multi-Centre Active Control Study Investigating the Efficacy and Safety of Imlifidase in Eliminating Donor Specific Anti-HLA Antibodies in the Treatment of Active Antibody-Mediated Rejection in Kidney Transplant Patients
The purpose of this study is to assess the effectiveness and safety of the study drug, imlifidase in patients who qualify for the study and ...Phase
Interventional
TRIAL ROLE: Sub Investigator
-
A Pivotal Phase 3 Trial to Evaluate the Safety and Efficacy of Clazakizumab for Treatment of Antibody-Mediated Rejection in Kidney Transplant Recipients
The purpose of this research study is to investigate the effectiveness and safety of treatment with clazakizumab compared to a placebo (inactive substance) in kidney ...Phase
Interventional
TRIAL ROLE: Sub Investigator
-
Prospective Multicenter Clinical Trial of HIV+ Deceased Donor Liver Transplants for HIV+ Recipients
The purpose of this study is to demonstrate the effectiveness of Riociguat as replacement of PDE-5i therapy (Sildenafil or Tadalafil) in patients with pulmonary arterial ...Phase N/A TRIAL ROLE: Sub Investigator
-
HOPE in Action Prospective Multicenter Clinical Trial of HIV+ Deceased Donor Kidney Transplants for HIV+ Recipients
The purpose of this study is to learn whether organ transplantation from HIV-positive deceased donors is as safe and effective in HIV-positive recipients as transplants ...Phase N/A TRIAL ROLE: Sub Investigator
